Jonathan R. Strosberg, et al. (Webcast presented by the Press office of ASCO-GI)
0 Views
administrator
07/09/23
Jonathan R. Strosberg, et al. NETTER-1 phase III: Progression-free survival, radiographic response, and preliminary overall survival results in patients with midgut neuroendocrine tumors treated with 177-Lu-Dotatate.
Show more
Facebook Comments
No comments found